Notice of Adoption of AMED Grant for Development of Production Methods Aimed at Practical Application of Regenerative Medical Products

Research project related to GAIA-102, conducted at the R&D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences of Kyushu University, has been adopted by AMED for ” Research Project for Practical Application of Regenerative Medicine”.

<Purpose of the Research>

Based on GAIA-102, perform functional modifications from the perspective of effectiveness without utilizing genetic engineering, further increasing manufacturing efficiency by over 10 times, enabling supply on a scale of 10,000 people per year with “CD3-negative allogeneic NK cell-like cell preparations” (GAIA-151).

<Overview of the Adopted Research Project>

Adopted Project Name: Research Project for Practical Application of Regenerative Medicine
Research and Development Task Name: Development of Mass Production Technology for Unique High-Functionality NK-like Cell Products Using Non-Genetically Modified Cell Modification Techniques
Research and Development Period: August 1, 2024 – March 31, 2027
Total Research Budget: ¥180,000,000-
Principal Investigator: Associate Prof. Yui HARADA (PhD, R&D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences of Kyushu University)

Share on